SlideShare una empresa de Scribd logo
1 de 30
Independent patient information Selling Sickness: Influence on influence - Amsterdam, 8 October 2010 Hilda Bastian, IQWiG, Germany
German healthcare reform of 2003 „In addition, as part of the Institute‘s mandate, it is to prepare information about the current status of scientific knowledge, so that citizens can benefit directly from its work.“ The goal: „to strengthen citizens‘ autonomy.“
IQWiG:  	German Institute for Quality and Efficiency		in Health Care Began work in October 2004 Legislative mandate: All of IQWiG's work is to be based on the principles and methods of evidence-based medicine Remit:  Effectiveness evaluations and patient information Can be commissioned by:
Ensuring scientific independence IQWiG:  Governance – the foundation and board Non-government, non-profit foundation established by legislation Board of governors include the Secretary of State for Health and representatives of the health care system self-governors (the statutory health insurance funds and service providers – hospitals and doctors) Funding through a levy on healthcare transactions
Ensuring stakeholder input IQWiG:  	Governance – the Board of Trustees Providers: medical and professional associations, hospitals Patients: Representatives of patient organisations, Federal Commissioner for Patients' Concerns Community: employers, churches Pharmaceutical industry
The long slow birth of the „Gesundfuchs“ Oct 2004:  IQWiG 2005:  Concept – but few resources Feb 2006:  Minister launches the website Dec 2006:  Evidence-based encyclopaedia proposal 2007:  Legislation expands IQWiG‘s mandate July 2007:  „Proof of concept“ approved 2008:  Green light - a team of 14 inside
Specialist expertise (plus IQWiG statistics department): Evidence assessment Clinical Communication Qualitative research External expertise
„Patient HTA“ Evidence scanning and assessment Assessing qualitative research International, bi-lingual peer review Stakeholder consultation on all drafts User-testing (focus groups) Post-publication criticism / correction system Kept up-to-date
Evidence-based patient information Developed using systematic methods to minimise bias and maintain neutrality Uncertainties addressed, as well as potential benefits and harms Kept up-to-date so that it remains evidence-based It‘s non-directive Uses evidence to try to achieve its aims (patients who are informed, psychologically supported and empowered to achieve their goals)
Empowering, patient-centred communication: Addresses what patients want to know Shows interest and respect for what patients think Respects patients‘ competence Dixon-Woods. Writing wrongs? An analysis of Published discourses about the use of patient Information leaflets. Soc Sci Med 2001;52:1417-1432. Kettunen et al. Developing empowering health Counseling measurement: preliminary results. Patient Educ Counsel 2006;64:159-166 Virtanen et al. Empowering discourse in patient Education. Patient Educ Counsel 2007;66:140-146
People telling their stories Angelika, 48 – the fear of bowel cancer (high risk) 	There were nights I lay awake for a long time and thought. There were some tears, too. I kept wondering if I was doing the right thing and how I could come to terms with the fear. It was damn hard. But those difficult times are a long time ago.
Determine scope and key messages Research (quantitative and qualitative) (possibly interviews and online survey) Commission Evidence scanning & Updating Development of products; Translation & translation QA Production Cycle & Quality Assurance User monitoring & evaluation Content QA (both languages) and IQWiG approval Reader feedback Stakeholder consultation (core products): IQWiG bodies including GBA, Ministry, and Board of Trustees plus German test readers (independent of IQWiG) Final version, Internal QA and IQWiG approval Publication
Two pathways for topic choice: Topic driven ,[object Object],[object Object]
Building an up-to-date evidence-based encyclopedia: Currently around 350 articles: aiming for 1,000 (plus a new form of medicines databank)
Evaluation Before and after publication Internal and external: qualitative and measurement (readability, usage etc) Methods and process evaluated by the WHO Regional Office for Europe
Trust and our readers They just say openly, „We don‘t know the answer.“ That is what I meant when I said, it‘s honest. That‘s just the way it is. Yet you hardly ever read that – it doesn‘t matter what kind of information, you know – that is usually completely missing.  (Are they believable?) I‘d say that, yes, for sure. I judge them to be very believable because of all those sources. You wouldn‘t just make up that many numbers.
As neutral and non-manipulative as humanly possible Directive patient information is not particularly effective and it is paternalistic A high level of expertise is needed to avoid and identify „spin“ „Spin can be defined as specific reporting that could distort the interpretation of results and mislead readers…(I)t can result from ignorance of the scientific issue, unconscious bias, or willful intent to deceive.“    Boutron (2010). JAMA; 303:2058-2064.
We occupy an uncomfortable position TRAITOR !
Competing for attention
Breaking out – of the niche and past the border
The future for evidence-based patient information
It‘s not easy, but it‘s not „MISSION: IMPOSSIBLE“
Conclusions: A core set of independent public patient information that could be widely translated / adapted is achievable and it is affordable But it needs support to thrive and become the most used information Good quality translation that preserves accuracy and quality of communication is essential – spin can be introduced during translation Patient information should not be medicines-driven, but driven by what patients want to know
Conclusions: We need better access to very basic product information in Europe – but its role can and should be tightly restricted We need a clear and simple mechanism for an authority such as IQWiG to correct errors and „spin“ in product information The regulators and the „new“ authorities need to create organisational and informational bridges, so that basic information about appropriate medicine use is linked to up-to-date evidence
Vielen Dank!www.informedhealthonline.org
Hilda Bastian - Selling Sickness 2010

Más contenido relacionado

La actualidad más candente

EWMA 2014 - EP466 LINK BETWEEN HOSPITAL-BASED DEPARTMENT OF WOUND HEALING AND...
EWMA 2014 - EP466 LINK BETWEEN HOSPITAL-BASED DEPARTMENT OF WOUND HEALING AND...EWMA 2014 - EP466 LINK BETWEEN HOSPITAL-BASED DEPARTMENT OF WOUND HEALING AND...
EWMA 2014 - EP466 LINK BETWEEN HOSPITAL-BASED DEPARTMENT OF WOUND HEALING AND...EWMA
 
Drug development and treatment strategies may go hand in hand.
Drug development and treatment strategies may go hand in hand.Drug development and treatment strategies may go hand in hand.
Drug development and treatment strategies may go hand in hand.EUPATI
 
PubDrug.org Brief History
PubDrug.org Brief HistoryPubDrug.org Brief History
PubDrug.org Brief HistoryStewart Brower
 
Patients at the Centre of Patient Safety byEPF
Patients at the Centre of Patient Safety byEPFPatients at the Centre of Patient Safety byEPF
Patients at the Centre of Patient Safety byEPFAtlantic Training, LLC.
 
Personal Health Records
Personal Health RecordsPersonal Health Records
Personal Health RecordsAyush Narula
 
Healthcare on CX Cloud
Healthcare on CX CloudHealthcare on CX Cloud
Healthcare on CX CloudSairah Rizvi
 
Patient engagement in clinical trials
Patient engagement in clinical trials Patient engagement in clinical trials
Patient engagement in clinical trials Martin Kelly
 
The Epidemiologist's Dream: Denmark
The Epidemiologist's Dream: DenmarkThe Epidemiologist's Dream: Denmark
The Epidemiologist's Dream: DenmarkZoe Mitchell
 
Ht ai 2015 poster final - The Maximum of Information in a Minimum of Words
Ht ai 2015 poster final - The Maximum of Information in a  Minimum of WordsHt ai 2015 poster final - The Maximum of Information in a  Minimum of Words
Ht ai 2015 poster final - The Maximum of Information in a Minimum of WordsREBRATSoficial
 
Ethical concerns caused by integrative patient empowerment services
Ethical concerns caused by integrative patient empowerment servicesEthical concerns caused by integrative patient empowerment services
Ethical concerns caused by integrative patient empowerment servicesWolfgang Kuchinke
 
Searching socialmediaforadverseevents
Searching socialmediaforadverseeventsSearching socialmediaforadverseevents
Searching socialmediaforadverseeventsAnn-Marie Roche
 
Increased Ethical Demands for Patient Empowerment in Personalised Medicine
Increased Ethical Demands for Patient Empowerment in Personalised MedicineIncreased Ethical Demands for Patient Empowerment in Personalised Medicine
Increased Ethical Demands for Patient Empowerment in Personalised MedicineWolfgang Kuchinke
 
Integrated Health Information to Examine, Empower and Engage
Integrated Health Information to Examine, Empower and EngageIntegrated Health Information to Examine, Empower and Engage
Integrated Health Information to Examine, Empower and EngageH-Connect Compusoft
 

La actualidad más candente (20)

Path dias uk 250314
Path dias uk 250314Path dias uk 250314
Path dias uk 250314
 
EWMA 2014 - EP466 LINK BETWEEN HOSPITAL-BASED DEPARTMENT OF WOUND HEALING AND...
EWMA 2014 - EP466 LINK BETWEEN HOSPITAL-BASED DEPARTMENT OF WOUND HEALING AND...EWMA 2014 - EP466 LINK BETWEEN HOSPITAL-BASED DEPARTMENT OF WOUND HEALING AND...
EWMA 2014 - EP466 LINK BETWEEN HOSPITAL-BASED DEPARTMENT OF WOUND HEALING AND...
 
Drug development and treatment strategies may go hand in hand.
Drug development and treatment strategies may go hand in hand.Drug development and treatment strategies may go hand in hand.
Drug development and treatment strategies may go hand in hand.
 
PubDrug.org Brief History
PubDrug.org Brief HistoryPubDrug.org Brief History
PubDrug.org Brief History
 
Patients at the Centre of Patient Safety byEPF
Patients at the Centre of Patient Safety byEPFPatients at the Centre of Patient Safety byEPF
Patients at the Centre of Patient Safety byEPF
 
Personal Health Records
Personal Health RecordsPersonal Health Records
Personal Health Records
 
Healthcare on CX Cloud
Healthcare on CX CloudHealthcare on CX Cloud
Healthcare on CX Cloud
 
Patient engagement in clinical trials
Patient engagement in clinical trials Patient engagement in clinical trials
Patient engagement in clinical trials
 
The Epidemiologist's Dream: Denmark
The Epidemiologist's Dream: DenmarkThe Epidemiologist's Dream: Denmark
The Epidemiologist's Dream: Denmark
 
0401 1 Denis Costello - Patient Generated Data
0401 1 Denis Costello - Patient Generated Data0401 1 Denis Costello - Patient Generated Data
0401 1 Denis Costello - Patient Generated Data
 
0401 2 Ananda Plate - Patient Preferences
0401 2 Ananda Plate - Patient Preferences0401 2 Ananda Plate - Patient Preferences
0401 2 Ananda Plate - Patient Preferences
 
Ht ai 2015 poster final - The Maximum of Information in a Minimum of Words
Ht ai 2015 poster final - The Maximum of Information in a  Minimum of WordsHt ai 2015 poster final - The Maximum of Information in a  Minimum of Words
Ht ai 2015 poster final - The Maximum of Information in a Minimum of Words
 
Ethical concerns caused by integrative patient empowerment services
Ethical concerns caused by integrative patient empowerment servicesEthical concerns caused by integrative patient empowerment services
Ethical concerns caused by integrative patient empowerment services
 
Jornadas #PatientInHTA · Gaizka Benguria
Jornadas #PatientInHTA · Gaizka BenguriaJornadas #PatientInHTA · Gaizka Benguria
Jornadas #PatientInHTA · Gaizka Benguria
 
Searching socialmediaforadverseevents
Searching socialmediaforadverseeventsSearching socialmediaforadverseevents
Searching socialmediaforadverseevents
 
Increased Ethical Demands for Patient Empowerment in Personalised Medicine
Increased Ethical Demands for Patient Empowerment in Personalised MedicineIncreased Ethical Demands for Patient Empowerment in Personalised Medicine
Increased Ethical Demands for Patient Empowerment in Personalised Medicine
 
Medical devices from patients' perspectives
Medical devices from patients' perspectivesMedical devices from patients' perspectives
Medical devices from patients' perspectives
 
Digitization in the emergency Department: the role of patient summaries
Digitization in the emergency Department: the role of patient summariesDigitization in the emergency Department: the role of patient summaries
Digitization in the emergency Department: the role of patient summaries
 
Portugal-patientsummaries
Portugal-patientsummariesPortugal-patientsummaries
Portugal-patientsummaries
 
Integrated Health Information to Examine, Empower and Engage
Integrated Health Information to Examine, Empower and EngageIntegrated Health Information to Examine, Empower and Engage
Integrated Health Information to Examine, Empower and Engage
 

Similar a Hilda Bastian - Selling Sickness 2010

EUPATI 2013 Conference: Building Knowledge & Competences for Patients’ Involv...
EUPATI 2013 Conference: Building Knowledge & Competences for Patients’ Involv...EUPATI 2013 Conference: Building Knowledge & Competences for Patients’ Involv...
EUPATI 2013 Conference: Building Knowledge & Competences for Patients’ Involv...EUPATI
 
Presenting health data to patients
Presenting health data to patientsPresenting health data to patients
Presenting health data to patientsKathleen Gray
 
EUPATI’s framework on Informing the “health-interested” public about medicine...
EUPATI’s framework on Informing the “health-interested” public about medicine...EUPATI’s framework on Informing the “health-interested” public about medicine...
EUPATI’s framework on Informing the “health-interested” public about medicine...Nowgen
 
Aysun Karatas MedicReS World Congress 2015
Aysun Karatas MedicReS World Congress 2015 Aysun Karatas MedicReS World Congress 2015
Aysun Karatas MedicReS World Congress 2015 MedicReS
 
Patient Advocates in Cancer Research: European Patients’ Perspective - Jan ...
Patient Advocates in Cancer Research: European Patients’ Perspective - Jan ...Patient Advocates in Cancer Research: European Patients’ Perspective - Jan ...
Patient Advocates in Cancer Research: European Patients’ Perspective - Jan ...patvocates
 
SHN 288408 D3_3 rev2 Annex 10_Rastall_SHN_D3_3_final
SHN 288408 D3_3 rev2 Annex 10_Rastall_SHN_D3_3_finalSHN 288408 D3_3 rev2 Annex 10_Rastall_SHN_D3_3_final
SHN 288408 D3_3 rev2 Annex 10_Rastall_SHN_D3_3_finalDarren Wooldridge
 
Pro instrument and its types - pubrica
Pro instrument and its types  - pubricaPro instrument and its types  - pubrica
Pro instrument and its types - pubricaPubrica
 
EPIS meeting - Dr Derick Mitchell - October 2017
EPIS meeting - Dr Derick Mitchell - October 2017EPIS meeting - Dr Derick Mitchell - October 2017
EPIS meeting - Dr Derick Mitchell - October 2017ipposi
 
Dissemination of HTA products. New lines of action. Marisa Lopez.
Dissemination of HTA products. New lines of action. Marisa Lopez.Dissemination of HTA products. New lines of action. Marisa Lopez.
Dissemination of HTA products. New lines of action. Marisa Lopez.HTAi Bilbao 2012
 
090714 los pacientes como protagonistas de la investigación clínica
090714 los pacientes como protagonistas de la investigación clínica090714 los pacientes como protagonistas de la investigación clínica
090714 los pacientes como protagonistas de la investigación clínicaJosè Leonardo Piscoya Arbañil
 
Education of patients (advocates) on R&D: European Patients’ Academy EUPATI...
Education of patients (advocates) on R&D: European Patients’ Academy EUPATI...Education of patients (advocates) on R&D: European Patients’ Academy EUPATI...
Education of patients (advocates) on R&D: European Patients’ Academy EUPATI...jangeissler
 
Implementing-Value-Based-Healthcare-In-Europe-EIT-Summit-2019
Implementing-Value-Based-Healthcare-In-Europe-EIT-Summit-2019Implementing-Value-Based-Healthcare-In-Europe-EIT-Summit-2019
Implementing-Value-Based-Healthcare-In-Europe-EIT-Summit-2019Massimo Talia
 
Digital Transformation In Healthcare_ Trends, Challenges And Solutions.pdf
Digital Transformation In Healthcare_ Trends, Challenges And Solutions.pdfDigital Transformation In Healthcare_ Trends, Challenges And Solutions.pdf
Digital Transformation In Healthcare_ Trends, Challenges And Solutions.pdfLucas Lagone
 
Tripartite dimension of interaction of patients, regulators and industry (Jan...
Tripartite dimension of interaction of patients, regulators and industry (Jan...Tripartite dimension of interaction of patients, regulators and industry (Jan...
Tripartite dimension of interaction of patients, regulators and industry (Jan...jangeissler
 
EU Clinical Trials Regulation - IPPOSI perspective
EU Clinical Trials Regulation - IPPOSI perspectiveEU Clinical Trials Regulation - IPPOSI perspective
EU Clinical Trials Regulation - IPPOSI perspectiveipposi
 
Jan Geissler - How Patient (Advocates) discuss Clinical Research on the Internet
Jan Geissler - How Patient (Advocates) discuss Clinical Research on the InternetJan Geissler - How Patient (Advocates) discuss Clinical Research on the Internet
Jan Geissler - How Patient (Advocates) discuss Clinical Research on the Internetpatvocates
 
EUPATI 2013 Conference: Vision on Patient involvement in medicines R&D: Here...
EUPATI 2013 Conference: Vision on Patient involvement in medicines R&D: Here...EUPATI 2013 Conference: Vision on Patient involvement in medicines R&D: Here...
EUPATI 2013 Conference: Vision on Patient involvement in medicines R&D: Here...EUPATI
 
Health information Seminar - Dr Derick Mitchell - Oct 2017
Health information Seminar - Dr Derick Mitchell - Oct 2017Health information Seminar - Dr Derick Mitchell - Oct 2017
Health information Seminar - Dr Derick Mitchell - Oct 2017ipposi
 

Similar a Hilda Bastian - Selling Sickness 2010 (20)

EUPATI 2013 Conference: Building Knowledge & Competences for Patients’ Involv...
EUPATI 2013 Conference: Building Knowledge & Competences for Patients’ Involv...EUPATI 2013 Conference: Building Knowledge & Competences for Patients’ Involv...
EUPATI 2013 Conference: Building Knowledge & Competences for Patients’ Involv...
 
Presenting health data to patients
Presenting health data to patientsPresenting health data to patients
Presenting health data to patients
 
EUPATI’s framework on Informing the “health-interested” public about medicine...
EUPATI’s framework on Informing the “health-interested” public about medicine...EUPATI’s framework on Informing the “health-interested” public about medicine...
EUPATI’s framework on Informing the “health-interested” public about medicine...
 
Aysun Karatas MedicReS World Congress 2015
Aysun Karatas MedicReS World Congress 2015 Aysun Karatas MedicReS World Congress 2015
Aysun Karatas MedicReS World Congress 2015
 
Patient Advocates in Cancer Research: European Patients’ Perspective - Jan ...
Patient Advocates in Cancer Research: European Patients’ Perspective - Jan ...Patient Advocates in Cancer Research: European Patients’ Perspective - Jan ...
Patient Advocates in Cancer Research: European Patients’ Perspective - Jan ...
 
SHN 288408 D3_3 rev2 Annex 10_Rastall_SHN_D3_3_final
SHN 288408 D3_3 rev2 Annex 10_Rastall_SHN_D3_3_finalSHN 288408 D3_3 rev2 Annex 10_Rastall_SHN_D3_3_final
SHN 288408 D3_3 rev2 Annex 10_Rastall_SHN_D3_3_final
 
Pro instrument and its types - pubrica
Pro instrument and its types  - pubricaPro instrument and its types  - pubrica
Pro instrument and its types - pubrica
 
EPIS meeting - Dr Derick Mitchell - October 2017
EPIS meeting - Dr Derick Mitchell - October 2017EPIS meeting - Dr Derick Mitchell - October 2017
EPIS meeting - Dr Derick Mitchell - October 2017
 
Dissemination of HTA products. New lines of action. Marisa Lopez.
Dissemination of HTA products. New lines of action. Marisa Lopez.Dissemination of HTA products. New lines of action. Marisa Lopez.
Dissemination of HTA products. New lines of action. Marisa Lopez.
 
090714 los pacientes como protagonistas de la investigación clínica
090714 los pacientes como protagonistas de la investigación clínica090714 los pacientes como protagonistas de la investigación clínica
090714 los pacientes como protagonistas de la investigación clínica
 
Education of patients (advocates) on R&D: European Patients’ Academy EUPATI...
Education of patients (advocates) on R&D: European Patients’ Academy EUPATI...Education of patients (advocates) on R&D: European Patients’ Academy EUPATI...
Education of patients (advocates) on R&D: European Patients’ Academy EUPATI...
 
MSNV 601 -
MSNV 601 - MSNV 601 -
MSNV 601 -
 
Implementing-Value-Based-Healthcare-In-Europe-EIT-Summit-2019
Implementing-Value-Based-Healthcare-In-Europe-EIT-Summit-2019Implementing-Value-Based-Healthcare-In-Europe-EIT-Summit-2019
Implementing-Value-Based-Healthcare-In-Europe-EIT-Summit-2019
 
Digital Transformation In Healthcare_ Trends, Challenges And Solutions.pdf
Digital Transformation In Healthcare_ Trends, Challenges And Solutions.pdfDigital Transformation In Healthcare_ Trends, Challenges And Solutions.pdf
Digital Transformation In Healthcare_ Trends, Challenges And Solutions.pdf
 
Tripartite dimension of interaction of patients, regulators and industry (Jan...
Tripartite dimension of interaction of patients, regulators and industry (Jan...Tripartite dimension of interaction of patients, regulators and industry (Jan...
Tripartite dimension of interaction of patients, regulators and industry (Jan...
 
EU Clinical Trials Regulation - IPPOSI perspective
EU Clinical Trials Regulation - IPPOSI perspectiveEU Clinical Trials Regulation - IPPOSI perspective
EU Clinical Trials Regulation - IPPOSI perspective
 
Jan Geissler - How Patient (Advocates) discuss Clinical Research on the Internet
Jan Geissler - How Patient (Advocates) discuss Clinical Research on the InternetJan Geissler - How Patient (Advocates) discuss Clinical Research on the Internet
Jan Geissler - How Patient (Advocates) discuss Clinical Research on the Internet
 
EUPATI 2013 Conference: Vision on Patient involvement in medicines R&D: Here...
EUPATI 2013 Conference: Vision on Patient involvement in medicines R&D: Here...EUPATI 2013 Conference: Vision on Patient involvement in medicines R&D: Here...
EUPATI 2013 Conference: Vision on Patient involvement in medicines R&D: Here...
 
0107 Jan Geissler - How drug development works and elements of trial protocols
0107 Jan Geissler - How drug development works and elements of trial protocols0107 Jan Geissler - How drug development works and elements of trial protocols
0107 Jan Geissler - How drug development works and elements of trial protocols
 
Health information Seminar - Dr Derick Mitchell - Oct 2017
Health information Seminar - Dr Derick Mitchell - Oct 2017Health information Seminar - Dr Derick Mitchell - Oct 2017
Health information Seminar - Dr Derick Mitchell - Oct 2017
 

Más de Gezonde scepsis

Trudy Dehue - Selling Sickness 2010
Trudy Dehue - Selling Sickness 2010Trudy Dehue - Selling Sickness 2010
Trudy Dehue - Selling Sickness 2010Gezonde scepsis
 
Teresa alves - selling sickness 2010
Teresa alves -  selling sickness 2010Teresa alves -  selling sickness 2010
Teresa alves - selling sickness 2010Gezonde scepsis
 
Peter Mansfield - Selling Sickness 2010
Peter Mansfield - Selling Sickness 2010Peter Mansfield - Selling Sickness 2010
Peter Mansfield - Selling Sickness 2010Gezonde scepsis
 
Michel Dutree - Selling Sickness 2010
Michel Dutree - Selling Sickness 2010Michel Dutree - Selling Sickness 2010
Michel Dutree - Selling Sickness 2010Gezonde scepsis
 
Lode Wigersma - Selling Sickness 2010
Lode Wigersma - Selling Sickness 2010Lode Wigersma - Selling Sickness 2010
Lode Wigersma - Selling Sickness 2010Gezonde scepsis
 
Bert Leufkens - Selling Sickness 2010
Bert Leufkens - Selling Sickness 2010Bert Leufkens - Selling Sickness 2010
Bert Leufkens - Selling Sickness 2010Gezonde scepsis
 
Kees de joncheere - Selling Sickness 2010
Kees de joncheere - Selling Sickness 2010Kees de joncheere - Selling Sickness 2010
Kees de joncheere - Selling Sickness 2010Gezonde scepsis
 
Henk Eleveld - Selling Sickness 2010
Henk Eleveld - Selling Sickness 2010Henk Eleveld - Selling Sickness 2010
Henk Eleveld - Selling Sickness 2010Gezonde scepsis
 
Graham Dukes - Selling Sickness 2010
Graham Dukes - Selling Sickness 2010Graham Dukes - Selling Sickness 2010
Graham Dukes - Selling Sickness 2010Gezonde scepsis
 
Meindert Boysen Selling Sickness 2010
Meindert Boysen Selling Sickness 2010Meindert Boysen Selling Sickness 2010
Meindert Boysen Selling Sickness 2010Gezonde scepsis
 
Ray Moynihan- Selling Sickness Amsterdam
Ray Moynihan- Selling Sickness AmsterdamRay Moynihan- Selling Sickness Amsterdam
Ray Moynihan- Selling Sickness AmsterdamGezonde scepsis
 
Ilaria passarani - Selling Sickness 2010
Ilaria passarani - Selling Sickness 2010Ilaria passarani - Selling Sickness 2010
Ilaria passarani - Selling Sickness 2010Gezonde scepsis
 
Brian Ager - Selling Sickness 2010
Brian Ager - Selling Sickness 2010Brian Ager - Selling Sickness 2010
Brian Ager - Selling Sickness 2010Gezonde scepsis
 
Dee Mangin Selling Sickness 2010
Dee Mangin Selling Sickness 2010Dee Mangin Selling Sickness 2010
Dee Mangin Selling Sickness 2010Gezonde scepsis
 
Dean Baker Selling Sickness 2010
Dean Baker Selling Sickness 2010Dean Baker Selling Sickness 2010
Dean Baker Selling Sickness 2010Gezonde scepsis
 
Allen frances dsm5 - Selling Sickness Conference 2010
Allen frances dsm5 - Selling Sickness Conference 2010Allen frances dsm5 - Selling Sickness Conference 2010
Allen frances dsm5 - Selling Sickness Conference 2010Gezonde scepsis
 

Más de Gezonde scepsis (17)

Trudy Dehue - Selling Sickness 2010
Trudy Dehue - Selling Sickness 2010Trudy Dehue - Selling Sickness 2010
Trudy Dehue - Selling Sickness 2010
 
Teresa alves - selling sickness 2010
Teresa alves -  selling sickness 2010Teresa alves -  selling sickness 2010
Teresa alves - selling sickness 2010
 
Peter Mansfield - Selling Sickness 2010
Peter Mansfield - Selling Sickness 2010Peter Mansfield - Selling Sickness 2010
Peter Mansfield - Selling Sickness 2010
 
Michel Dutree - Selling Sickness 2010
Michel Dutree - Selling Sickness 2010Michel Dutree - Selling Sickness 2010
Michel Dutree - Selling Sickness 2010
 
Lode Wigersma - Selling Sickness 2010
Lode Wigersma - Selling Sickness 2010Lode Wigersma - Selling Sickness 2010
Lode Wigersma - Selling Sickness 2010
 
Bert Leufkens - Selling Sickness 2010
Bert Leufkens - Selling Sickness 2010Bert Leufkens - Selling Sickness 2010
Bert Leufkens - Selling Sickness 2010
 
Kees de joncheere - Selling Sickness 2010
Kees de joncheere - Selling Sickness 2010Kees de joncheere - Selling Sickness 2010
Kees de joncheere - Selling Sickness 2010
 
Henk Eleveld - Selling Sickness 2010
Henk Eleveld - Selling Sickness 2010Henk Eleveld - Selling Sickness 2010
Henk Eleveld - Selling Sickness 2010
 
Graham Dukes - Selling Sickness 2010
Graham Dukes - Selling Sickness 2010Graham Dukes - Selling Sickness 2010
Graham Dukes - Selling Sickness 2010
 
Meindert Boysen Selling Sickness 2010
Meindert Boysen Selling Sickness 2010Meindert Boysen Selling Sickness 2010
Meindert Boysen Selling Sickness 2010
 
Ray Moynihan- Selling Sickness Amsterdam
Ray Moynihan- Selling Sickness AmsterdamRay Moynihan- Selling Sickness Amsterdam
Ray Moynihan- Selling Sickness Amsterdam
 
Josée hansen igz
Josée hansen   igzJosée hansen   igz
Josée hansen igz
 
Ilaria passarani - Selling Sickness 2010
Ilaria passarani - Selling Sickness 2010Ilaria passarani - Selling Sickness 2010
Ilaria passarani - Selling Sickness 2010
 
Brian Ager - Selling Sickness 2010
Brian Ager - Selling Sickness 2010Brian Ager - Selling Sickness 2010
Brian Ager - Selling Sickness 2010
 
Dee Mangin Selling Sickness 2010
Dee Mangin Selling Sickness 2010Dee Mangin Selling Sickness 2010
Dee Mangin Selling Sickness 2010
 
Dean Baker Selling Sickness 2010
Dean Baker Selling Sickness 2010Dean Baker Selling Sickness 2010
Dean Baker Selling Sickness 2010
 
Allen frances dsm5 - Selling Sickness Conference 2010
Allen frances dsm5 - Selling Sickness Conference 2010Allen frances dsm5 - Selling Sickness Conference 2010
Allen frances dsm5 - Selling Sickness Conference 2010
 

Último

ROLES IN A STAGE PRODUCTION in arts.pptx
ROLES IN A STAGE PRODUCTION in arts.pptxROLES IN A STAGE PRODUCTION in arts.pptx
ROLES IN A STAGE PRODUCTION in arts.pptxVanesaIglesias10
 
Keynote by Prof. Wurzer at Nordex about IP-design
Keynote by Prof. Wurzer at Nordex about IP-designKeynote by Prof. Wurzer at Nordex about IP-design
Keynote by Prof. Wurzer at Nordex about IP-designMIPLM
 
USPS® Forced Meter Migration - How to Know if Your Postage Meter Will Soon be...
USPS® Forced Meter Migration - How to Know if Your Postage Meter Will Soon be...USPS® Forced Meter Migration - How to Know if Your Postage Meter Will Soon be...
USPS® Forced Meter Migration - How to Know if Your Postage Meter Will Soon be...Postal Advocate Inc.
 
Influencing policy (training slides from Fast Track Impact)
Influencing policy (training slides from Fast Track Impact)Influencing policy (training slides from Fast Track Impact)
Influencing policy (training slides from Fast Track Impact)Mark Reed
 
AUDIENCE THEORY -CULTIVATION THEORY - GERBNER.pptx
AUDIENCE THEORY -CULTIVATION THEORY -  GERBNER.pptxAUDIENCE THEORY -CULTIVATION THEORY -  GERBNER.pptx
AUDIENCE THEORY -CULTIVATION THEORY - GERBNER.pptxiammrhaywood
 
Dust Of Snow By Robert Frost Class-X English CBSE
Dust Of Snow By Robert Frost Class-X English CBSEDust Of Snow By Robert Frost Class-X English CBSE
Dust Of Snow By Robert Frost Class-X English CBSEaurabinda banchhor
 
Virtual-Orientation-on-the-Administration-of-NATG12-NATG6-and-ELLNA.pdf
Virtual-Orientation-on-the-Administration-of-NATG12-NATG6-and-ELLNA.pdfVirtual-Orientation-on-the-Administration-of-NATG12-NATG6-and-ELLNA.pdf
Virtual-Orientation-on-the-Administration-of-NATG12-NATG6-and-ELLNA.pdfErwinPantujan2
 
Choosing the Right CBSE School A Comprehensive Guide for Parents
Choosing the Right CBSE School A Comprehensive Guide for ParentsChoosing the Right CBSE School A Comprehensive Guide for Parents
Choosing the Right CBSE School A Comprehensive Guide for Parentsnavabharathschool99
 
Expanded definition: technical and operational
Expanded definition: technical and operationalExpanded definition: technical and operational
Expanded definition: technical and operationalssuser3e220a
 
Active Learning Strategies (in short ALS).pdf
Active Learning Strategies (in short ALS).pdfActive Learning Strategies (in short ALS).pdf
Active Learning Strategies (in short ALS).pdfPatidar M
 
Daily Lesson Plan in Mathematics Quarter 4
Daily Lesson Plan in Mathematics Quarter 4Daily Lesson Plan in Mathematics Quarter 4
Daily Lesson Plan in Mathematics Quarter 4JOYLYNSAMANIEGO
 
The Contemporary World: The Globalization of World Politics
The Contemporary World: The Globalization of World PoliticsThe Contemporary World: The Globalization of World Politics
The Contemporary World: The Globalization of World PoliticsRommel Regala
 
ICS2208 Lecture6 Notes for SL spaces.pdf
ICS2208 Lecture6 Notes for SL spaces.pdfICS2208 Lecture6 Notes for SL spaces.pdf
ICS2208 Lecture6 Notes for SL spaces.pdfVanessa Camilleri
 
Millenials and Fillennials (Ethical Challenge and Responses).pptx
Millenials and Fillennials (Ethical Challenge and Responses).pptxMillenials and Fillennials (Ethical Challenge and Responses).pptx
Millenials and Fillennials (Ethical Challenge and Responses).pptxJanEmmanBrigoli
 
Field Attribute Index Feature in Odoo 17
Field Attribute Index Feature in Odoo 17Field Attribute Index Feature in Odoo 17
Field Attribute Index Feature in Odoo 17Celine George
 
4.16.24 21st Century Movements for Black Lives.pptx
4.16.24 21st Century Movements for Black Lives.pptx4.16.24 21st Century Movements for Black Lives.pptx
4.16.24 21st Century Movements for Black Lives.pptxmary850239
 
Grade 9 Quarter 4 Dll Grade 9 Quarter 4 DLL.pdf
Grade 9 Quarter 4 Dll Grade 9 Quarter 4 DLL.pdfGrade 9 Quarter 4 Dll Grade 9 Quarter 4 DLL.pdf
Grade 9 Quarter 4 Dll Grade 9 Quarter 4 DLL.pdfJemuel Francisco
 
Visit to a blind student's school🧑‍🦯🧑‍🦯(community medicine)
Visit to a blind student's school🧑‍🦯🧑‍🦯(community medicine)Visit to a blind student's school🧑‍🦯🧑‍🦯(community medicine)
Visit to a blind student's school🧑‍🦯🧑‍🦯(community medicine)lakshayb543
 
GRADE 4 - SUMMATIVE TEST QUARTER 4 ALL SUBJECTS
GRADE 4 - SUMMATIVE TEST QUARTER 4 ALL SUBJECTSGRADE 4 - SUMMATIVE TEST QUARTER 4 ALL SUBJECTS
GRADE 4 - SUMMATIVE TEST QUARTER 4 ALL SUBJECTSJoshuaGantuangco2
 

Último (20)

LEFT_ON_C'N_ PRELIMS_EL_DORADO_2024.pptx
LEFT_ON_C'N_ PRELIMS_EL_DORADO_2024.pptxLEFT_ON_C'N_ PRELIMS_EL_DORADO_2024.pptx
LEFT_ON_C'N_ PRELIMS_EL_DORADO_2024.pptx
 
ROLES IN A STAGE PRODUCTION in arts.pptx
ROLES IN A STAGE PRODUCTION in arts.pptxROLES IN A STAGE PRODUCTION in arts.pptx
ROLES IN A STAGE PRODUCTION in arts.pptx
 
Keynote by Prof. Wurzer at Nordex about IP-design
Keynote by Prof. Wurzer at Nordex about IP-designKeynote by Prof. Wurzer at Nordex about IP-design
Keynote by Prof. Wurzer at Nordex about IP-design
 
USPS® Forced Meter Migration - How to Know if Your Postage Meter Will Soon be...
USPS® Forced Meter Migration - How to Know if Your Postage Meter Will Soon be...USPS® Forced Meter Migration - How to Know if Your Postage Meter Will Soon be...
USPS® Forced Meter Migration - How to Know if Your Postage Meter Will Soon be...
 
Influencing policy (training slides from Fast Track Impact)
Influencing policy (training slides from Fast Track Impact)Influencing policy (training slides from Fast Track Impact)
Influencing policy (training slides from Fast Track Impact)
 
AUDIENCE THEORY -CULTIVATION THEORY - GERBNER.pptx
AUDIENCE THEORY -CULTIVATION THEORY -  GERBNER.pptxAUDIENCE THEORY -CULTIVATION THEORY -  GERBNER.pptx
AUDIENCE THEORY -CULTIVATION THEORY - GERBNER.pptx
 
Dust Of Snow By Robert Frost Class-X English CBSE
Dust Of Snow By Robert Frost Class-X English CBSEDust Of Snow By Robert Frost Class-X English CBSE
Dust Of Snow By Robert Frost Class-X English CBSE
 
Virtual-Orientation-on-the-Administration-of-NATG12-NATG6-and-ELLNA.pdf
Virtual-Orientation-on-the-Administration-of-NATG12-NATG6-and-ELLNA.pdfVirtual-Orientation-on-the-Administration-of-NATG12-NATG6-and-ELLNA.pdf
Virtual-Orientation-on-the-Administration-of-NATG12-NATG6-and-ELLNA.pdf
 
Choosing the Right CBSE School A Comprehensive Guide for Parents
Choosing the Right CBSE School A Comprehensive Guide for ParentsChoosing the Right CBSE School A Comprehensive Guide for Parents
Choosing the Right CBSE School A Comprehensive Guide for Parents
 
Expanded definition: technical and operational
Expanded definition: technical and operationalExpanded definition: technical and operational
Expanded definition: technical and operational
 
Active Learning Strategies (in short ALS).pdf
Active Learning Strategies (in short ALS).pdfActive Learning Strategies (in short ALS).pdf
Active Learning Strategies (in short ALS).pdf
 
Daily Lesson Plan in Mathematics Quarter 4
Daily Lesson Plan in Mathematics Quarter 4Daily Lesson Plan in Mathematics Quarter 4
Daily Lesson Plan in Mathematics Quarter 4
 
The Contemporary World: The Globalization of World Politics
The Contemporary World: The Globalization of World PoliticsThe Contemporary World: The Globalization of World Politics
The Contemporary World: The Globalization of World Politics
 
ICS2208 Lecture6 Notes for SL spaces.pdf
ICS2208 Lecture6 Notes for SL spaces.pdfICS2208 Lecture6 Notes for SL spaces.pdf
ICS2208 Lecture6 Notes for SL spaces.pdf
 
Millenials and Fillennials (Ethical Challenge and Responses).pptx
Millenials and Fillennials (Ethical Challenge and Responses).pptxMillenials and Fillennials (Ethical Challenge and Responses).pptx
Millenials and Fillennials (Ethical Challenge and Responses).pptx
 
Field Attribute Index Feature in Odoo 17
Field Attribute Index Feature in Odoo 17Field Attribute Index Feature in Odoo 17
Field Attribute Index Feature in Odoo 17
 
4.16.24 21st Century Movements for Black Lives.pptx
4.16.24 21st Century Movements for Black Lives.pptx4.16.24 21st Century Movements for Black Lives.pptx
4.16.24 21st Century Movements for Black Lives.pptx
 
Grade 9 Quarter 4 Dll Grade 9 Quarter 4 DLL.pdf
Grade 9 Quarter 4 Dll Grade 9 Quarter 4 DLL.pdfGrade 9 Quarter 4 Dll Grade 9 Quarter 4 DLL.pdf
Grade 9 Quarter 4 Dll Grade 9 Quarter 4 DLL.pdf
 
Visit to a blind student's school🧑‍🦯🧑‍🦯(community medicine)
Visit to a blind student's school🧑‍🦯🧑‍🦯(community medicine)Visit to a blind student's school🧑‍🦯🧑‍🦯(community medicine)
Visit to a blind student's school🧑‍🦯🧑‍🦯(community medicine)
 
GRADE 4 - SUMMATIVE TEST QUARTER 4 ALL SUBJECTS
GRADE 4 - SUMMATIVE TEST QUARTER 4 ALL SUBJECTSGRADE 4 - SUMMATIVE TEST QUARTER 4 ALL SUBJECTS
GRADE 4 - SUMMATIVE TEST QUARTER 4 ALL SUBJECTS
 

Hilda Bastian - Selling Sickness 2010

  • 1. Independent patient information Selling Sickness: Influence on influence - Amsterdam, 8 October 2010 Hilda Bastian, IQWiG, Germany
  • 2. German healthcare reform of 2003 „In addition, as part of the Institute‘s mandate, it is to prepare information about the current status of scientific knowledge, so that citizens can benefit directly from its work.“ The goal: „to strengthen citizens‘ autonomy.“
  • 3. IQWiG: German Institute for Quality and Efficiency in Health Care Began work in October 2004 Legislative mandate: All of IQWiG's work is to be based on the principles and methods of evidence-based medicine Remit: Effectiveness evaluations and patient information Can be commissioned by:
  • 4. Ensuring scientific independence IQWiG: Governance – the foundation and board Non-government, non-profit foundation established by legislation Board of governors include the Secretary of State for Health and representatives of the health care system self-governors (the statutory health insurance funds and service providers – hospitals and doctors) Funding through a levy on healthcare transactions
  • 5. Ensuring stakeholder input IQWiG: Governance – the Board of Trustees Providers: medical and professional associations, hospitals Patients: Representatives of patient organisations, Federal Commissioner for Patients' Concerns Community: employers, churches Pharmaceutical industry
  • 6. The long slow birth of the „Gesundfuchs“ Oct 2004: IQWiG 2005: Concept – but few resources Feb 2006: Minister launches the website Dec 2006: Evidence-based encyclopaedia proposal 2007: Legislation expands IQWiG‘s mandate July 2007: „Proof of concept“ approved 2008: Green light - a team of 14 inside
  • 7. Specialist expertise (plus IQWiG statistics department): Evidence assessment Clinical Communication Qualitative research External expertise
  • 8.
  • 9. „Patient HTA“ Evidence scanning and assessment Assessing qualitative research International, bi-lingual peer review Stakeholder consultation on all drafts User-testing (focus groups) Post-publication criticism / correction system Kept up-to-date
  • 10. Evidence-based patient information Developed using systematic methods to minimise bias and maintain neutrality Uncertainties addressed, as well as potential benefits and harms Kept up-to-date so that it remains evidence-based It‘s non-directive Uses evidence to try to achieve its aims (patients who are informed, psychologically supported and empowered to achieve their goals)
  • 11. Empowering, patient-centred communication: Addresses what patients want to know Shows interest and respect for what patients think Respects patients‘ competence Dixon-Woods. Writing wrongs? An analysis of Published discourses about the use of patient Information leaflets. Soc Sci Med 2001;52:1417-1432. Kettunen et al. Developing empowering health Counseling measurement: preliminary results. Patient Educ Counsel 2006;64:159-166 Virtanen et al. Empowering discourse in patient Education. Patient Educ Counsel 2007;66:140-146
  • 12. People telling their stories Angelika, 48 – the fear of bowel cancer (high risk) There were nights I lay awake for a long time and thought. There were some tears, too. I kept wondering if I was doing the right thing and how I could come to terms with the fear. It was damn hard. But those difficult times are a long time ago.
  • 13. Determine scope and key messages Research (quantitative and qualitative) (possibly interviews and online survey) Commission Evidence scanning & Updating Development of products; Translation & translation QA Production Cycle & Quality Assurance User monitoring & evaluation Content QA (both languages) and IQWiG approval Reader feedback Stakeholder consultation (core products): IQWiG bodies including GBA, Ministry, and Board of Trustees plus German test readers (independent of IQWiG) Final version, Internal QA and IQWiG approval Publication
  • 14.
  • 15.
  • 16.
  • 17. Building an up-to-date evidence-based encyclopedia: Currently around 350 articles: aiming for 1,000 (plus a new form of medicines databank)
  • 18. Evaluation Before and after publication Internal and external: qualitative and measurement (readability, usage etc) Methods and process evaluated by the WHO Regional Office for Europe
  • 19. Trust and our readers They just say openly, „We don‘t know the answer.“ That is what I meant when I said, it‘s honest. That‘s just the way it is. Yet you hardly ever read that – it doesn‘t matter what kind of information, you know – that is usually completely missing. (Are they believable?) I‘d say that, yes, for sure. I judge them to be very believable because of all those sources. You wouldn‘t just make up that many numbers.
  • 20. As neutral and non-manipulative as humanly possible Directive patient information is not particularly effective and it is paternalistic A high level of expertise is needed to avoid and identify „spin“ „Spin can be defined as specific reporting that could distort the interpretation of results and mislead readers…(I)t can result from ignorance of the scientific issue, unconscious bias, or willful intent to deceive.“ Boutron (2010). JAMA; 303:2058-2064.
  • 21. We occupy an uncomfortable position TRAITOR !
  • 22.
  • 24. Breaking out – of the niche and past the border
  • 25. The future for evidence-based patient information
  • 26. It‘s not easy, but it‘s not „MISSION: IMPOSSIBLE“
  • 27. Conclusions: A core set of independent public patient information that could be widely translated / adapted is achievable and it is affordable But it needs support to thrive and become the most used information Good quality translation that preserves accuracy and quality of communication is essential – spin can be introduced during translation Patient information should not be medicines-driven, but driven by what patients want to know
  • 28. Conclusions: We need better access to very basic product information in Europe – but its role can and should be tightly restricted We need a clear and simple mechanism for an authority such as IQWiG to correct errors and „spin“ in product information The regulators and the „new“ authorities need to create organisational and informational bridges, so that basic information about appropriate medicine use is linked to up-to-date evidence